Active	Status	Sponsor type	Region	Phase	Filter
4 Active 0 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Kamel, Hooman
ASPIRE, NCT03907046: Anticoagulation in ICH Survivors for Stroke Prevention and Recovery	Recruiting	3	700	US	Apixaban, Eliquis, Aspirin	Yale University, National Institute of Neurological Disorders and Stroke (NINDS)	Intracerebral Hemorrhage, Atrial Fibrillation	04/27	04/27
Mathew, Jason
ASPIRE, NCT03907046: Anticoagulation in ICH Survivors for Stroke Prevention and Recovery	Recruiting	3	700	US	Apixaban, Eliquis, Aspirin	Yale University, National Institute of Neurological Disorders and Stroke (NINDS)	Intracerebral Hemorrhage, Atrial Fibrillation	04/27	04/27
FASTEST, NCT03496883: Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial	Recruiting	3	860	Europe, Canada, Japan, US	Recombinant Activated Factor VII (rFVIIa), NovoSeven, NiaStase, Placebo	Joseph Broderick, MD, Novo Nordisk A/S, National Institute of Neurological Disorders and Stroke (NINDS)	Intracerebral Hemorrhage	01/28	01/28
NCT06401564: Virtual Reality Based Rehabilitation After Ischemic Stroke	Recruiting	N/A	15	US	Virtual Reality Therapy	Stony Brook University, Good Samaritan Hospital	Ischemic Stroke	12/25	12/26